A
Menu
First published December 11, 2024 Application Aachen patent A – Human necessities

ANTHRACYCLINES

Espacenet Family 86732273

Abstract

Provided herein are compounds useful in the treatment of cancer, as well as formulations and compositions comprising such compounds. Also provided is the use of such compounds, formulations and compositions as a medicament, for example in the treatment of cancer. The compounds are of formula I:or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof. R<sup>1</sup> is a substituted or unsubstituted C<sub>1-4</sub> alkyl. R<sup>2</sup> is a substituted or unsubstituted C<sub>1-4</sub> alkyl. R<sup>3</sup> is selected from H, monosaccharide, and disaccharide. R<sup>4</sup> is selected from H, and OH.

Inventors 5

  1. Jacques Neefjes Aachen author as filed: Neefjes, Jacques J.C.
  2. Herman S. Overkleeft Aachen author as filed: Overkleeft, Herman S.
  3. Dennis P. A. Wander Aachen author as filed: Wander, Dennis P.A.
  4. Sabina Y. van der Zanden Aachen author as filed: van der Zanden, Sabina Y.
  5. Merle A. van Gelder Aachen author as filed: van Gelder, Merle A.

Inventors are linked to an Aachen author when surname and first name match exactly one author.

Applicants

  • Academisch Ziekenhuis Leiden h.o.d.n. LUMC GBS Leiden

Cited papers 2 in the database

Non-patent literature as cited (15)
  • - "Bioreversible Carriers in Drug Design", vol. 14, 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS, article "Pro-drugs as Novel Delivery Systems"
  • - "Design of Prodrugs", 1985, ELSEVIER
  • - JUDKINS ET AL., SYNTHETIC COMMUNICATIONS, vol. 26, no. 23, 1996, pages 4351 - 4367
  • - RICHARD B SILVERMAN, THE ORGANIC CHEMISTRY OF DRUG DESIGN AND DRUG ACTION, pages 497 - 546
  • - R. GRAESER ET AL.: "INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model", INVESTIGATIONAL NEW DRUGS, vol. 28, no. 1, 2009, pages 14 - 9, XP019768224
  • - BERGE ET AL.: "Pharmaceutical Salts", JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 1 - 19, XP002675560, DOI: 10.1002/jps.2600660104
  • - GOODMANGILLMAN'S ET AL.: "The Pharmacological Bases of Therapeutics", 1990, MACK PUBLISHING CO
  • - VVLODEK DBANATH JOLIVE P. L, INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, vol. 60, no. 5, 1991, pages 779 - 790
  • - PANG, BQIAO, XJANSSEN, L ET AL., NAT COMMUN, vol. 4, 1908, pages 2013
  • - VLLANDER D. P. AVAN DER ZANDEN S. Y ET AL., J MED CHEM, vol. 63, no. 21, 2020, pages 12814 - 12829
  • - WANDERD. P. AVAN DER ZANDEN S. Y ET AL., J ORG CHEM, vol. 86, no. 8, 2021, pages 5757 - 5770
  • - PANG, BQIAO, XJANSSEN, L. ET AL., NAT COMMUN, vol. 4, 2013, pages 1908
  • - KUO, L. JYANG, L. X, IN VIVO, April 2008 (2008-04-01), pages 305 - 310
  • - QIAO XIAOHANG ET AL: "Uncoupling DNA damage from chromatin damage to detoxify doxorubicin", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 117, no. 26, 17 June 2020 (2020-06-17), pages 15182 - 15192, XP093100975, ISSN: 0027-8424, Retrieved from the Internet <URL:http://dx.doi.org/10.1073/pnas.1922072117> DOI: 10.1073/pnas.1922072117
  • - WANDER DENNIS P. A. ET AL: "Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents", JOURNAL OF MEDICINAL CHEMISTRY, vol. 63, no. 21, 16 October 2020 (2020-10-16), US, pages 12814 - 12829, XP093100971, ISSN: 0022-2623, Retrieved from the Internet <URL:http://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01191> DOI: 10.1021/acs.jmedchem.0c01191

Cited patents 1

US5496808A